We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+8.65%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.68B
AUM Growth
+$147M
Cap. Flow
-$35.9M
Cap. Flow %
-1.34%
Top 10 Hldgs %
23.74%
Holding
195
New
2
Increased
35
Reduced
62
Closed
9

Top Buys

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$20.5M
2
HEI icon
HEICO Corp
HEI
+$15.4M
3
WRB icon
W.R. Berkley
WRB
+$12M
4
WCN
Waste Connections
WCN
+$10.3M
5
IT icon
Gartner
IT
+$7.22M

Top Sells

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$23.3M
2
INTU icon
Intuit
INTU
+$20.6M
3
ACN icon
Accenture
ACN
+$13.9M
4
NOW icon
ServiceNow
NOW
+$12M
5
CDNS icon
Cadence Design Systems
CDNS
+$9.14M

Sector Composition

Rank Sector Weight
1 Technology 34.59%
2 Industrials 21.71%
3 Healthcare 15.27%
4 Financials 13.4%
5 Consumer Discretionary 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTS icon
76
Watts Water Technologies
WTS
$11.2B
$9.76M 0.36%
53,147
– –
SPLK
77
DELISTED
Splunk Inc
SPLK
$9.76M 0.36%
92,000
-2,000
-2% -$190K
USPH icon
78
US Physical Therapy
USPH
$1.22B
$9.44M 0.35%
77,800
– –
MTCH icon
79
Match Group
MTCH
$9.19B
$9.29M 0.35%
222,000
-3,000
-1% -$110K
MSCI icon
80
MSCI
MSCI
$42.4B
$8.92M 0.33%
19,000
+4,000
+27% +$1.95M
WDAY icon
81
Workday
WDAY
$41.5B
$8.72M 0.32%
38,600
-5,400
-12% -$1.08M
BMRN icon
82
BioMarin Pharmaceuticals
BMRN
$11.9B
$8.24M 0.31%
95,036
+10,002
+12% +$941K
SLGN icon
83
Silgan Holdings
SLGN
$4.51B
$8.09M 0.3%
172,600
– –
CROX icon
84
Crocs
CROX
$6.63B
$8.06M 0.3%
71,700
– –
BABA icon
85
Alibaba
BABA
$276B
$7.92M 0.3%
95,000
+8,000
+9% +$700K
EME icon
86
Emcor
EME
$29.9B
$7.88M 0.29%
42,622
+15,200
+55% +$2.54M
WK icon
87
Workiva
WK
$3.45B
$7.77M 0.29%
76,400
– –
CRWD icon
88
CrowdStrike
CRWD
$183B
$7.34M 0.27%
200,000
-12,000
-6% -$418K
RIVN icon
89
Rivian
RIVN
$23.6B
$7.33M 0.27%
440,000
+240,000
+120% +$3.35M
LULU icon
90
lululemon athletica
LULU
$13.5B
$7.31M 0.27%
19,300
-2,700
-12% -$996K
ENSG icon
91
The Ensign Group
ENSG
$10.6B
$7.3M 0.27%
76,500
– –
ULTA icon
92
Ulta Beauty
ULTA
$21.8B
$7.26M 0.27%
15,417
-698
-4% -$342K
FIVN icon
93
FIVE9
FIVN
$2.08B
$6.92M 0.26%
83,900
– –
FCN icon
94
FTI Consulting
FCN
$5.14B
$6.89M 0.26%
36,200
– –
PYPL icon
95
PayPal
PYPL
$49.9B
$6.67M 0.25%
100,000
-14,000
-12% -$954K
SNAP icon
96
Snap
SNAP
$7.96B
$6.63M 0.25%
560,000
+65,000
+13% +$653K
DIS icon
97
Walt Disney
DIS
$171B
$6.61M 0.25%
74,000
-5,000
-6% -$474K
COO icon
98
Cooper Companies
COO
$14.2B
$6.59M 0.25%
68,800
– –
LSTR icon
99
Landstar System
LSTR
$6.04B
$6.51M 0.24%
33,800
– –
BLD
100
DELISTED
TopBuild
BLD
$6.49M 0.24%
24,400
– –
2 3
4
5 6

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return

EULAV Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, EULAV Asset Management held 195 positions worth $2.68B, up 5.8% from $2.54B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

EULAV Asset Management's Q2 2023 filing shows 2 new, 35 increased, 62 reduced and 9 closed positions. Its largest new stake was Getty Images: 400,000 shares worth $1.95M. The largest sale was S&P Global, an estimated $23.3M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Industrials and Healthcare.

  • EULAV Asset Management's largest Q2 2023 buy was Getty Images: 400,000 shares worth $1.95M.
  • EULAV Asset Management added most to West Pharmaceutical in Q2 2023, an estimated $20.5M increase.
  • EULAV Asset Management's biggest Q2 2023 reduction was S&P Global, cutting an estimated $23.3M.
  • EULAV Asset Management fully exited Bio-Rad Laboratories Class A in Q2 2023, selling an estimated $6.51M.
  • EULAV Asset Management's ten largest holdings make up 24% of its $2.68B portfolio in Q2 2023.
  • EULAV Asset Management opened 2 new positions and closed 9 in Q2 2023.
  • EULAV Asset Management's portfolio value rose 5.8% quarter-over-quarter to $2.68B.

Based on EULAV Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.